Determination of antibodies directed at EBV proteins expressed in both latent and lytic cycles in nasopharyngeal carcinoma

Oral Oncology

Volumn 49, Issue 4, 2013, Pages 326-331

  Ai, Ping ^b   Wang, Tao ^a   Zhang, Hong ^b   Wang, Yanyun ^a   Song, Changping ^a   Zhang, Lin ^a   Li, Zhiping ^b   Hu, Huaizhong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

EA antibody; EBV antibody; NA1 antibody; Nasopharyngeal carcinoma; Rta antibody; VCA antibody

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER THERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; VIRAL PROTEINS;

EID: 84875277335     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.10.001     Document Type: Article

References (33)

1. M.C. Yu, and J.M. Yuan Epidemiology of nasopharyngeal carcinoma Semin Cancer Biol 12 2002 421 429
2. A.T. Chan Nasopharyngeal carcinoma Ann Oncol 21 Suppl. 7 2010 vii308 vii312
3. J.C. Lin, J.S. Jan, C.Y. Hsu, W.M. Liang, R.S. Jiang, and W.Y. Wang Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
4. A.W. Lee, W.M. Sze, J.S. Au, S.F. Leung, T.W. Leung, and D.T. Chua Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 2005 1107 1116
5. S.H. Cheng, J.J. Jian, S.Y. Tsai, K.L. Yen, N.M. Chu, and K.Y. Chan Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy Int J Radiat Oncol Biol Phys 48 2000 1323 1330
6. P. Gunven Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients Nature 228 1970 1053 1056
7. J. Fachiroh, T. Schouten, B. Hariwiyanto, D.K. Paramita, A. Harijadi, and S.M. Haryana Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects J Infect Dis 190 2004 53 62
8. Y.C. Chien, J.Y. Chen, M.Y. Liu, H.I. Yang, M.M. Hsu, and C.J. Chen Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men N Engl J Med 345 2001 1877 1882
9. A. Rodriguez, M. Armstrong, D. Dwyer, and E. Flemington Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta J Virol 73 1999 9029 9038
10. G. Henle, and W. Henle Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma Int J Cancer 17 1976 1 7
11. E.C. Nadala, T.M. Tan, H.M. Wong, and R.C. Ting ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus J Med Virol 50 1996 93 96
12. H.M. Cheng, Y.T. Foong, C.K. Sam, U. Prasad, and J. Dillner Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors J Clin Microbiol 29 1991 2180 2186
13. T.T. Yip, R.K. Ngan, W.H. Lau, Y.F. Poon, I. Joab, and C. Cochet A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma Cancer 74 1994 2414 2424
14. P. Feng, E.C. Ren, D. Liu, S.H. Chan, and H. Hu Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis J Gen Virol 81 2000 2417 2423
15. J.W. Tang, E. Rohwader, I.M. Chu, R.K. Tsang, K. Steinhagen, and A.C. Yeung Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma J Clin Virol 40 2007 248 284
16. D.K. Paramita, J. Fachiroh, S.M. Haryana, and J.M. Middeldorp Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma J Clin Virol 42 2008 343 352
17. W.C. Cho Nasopharyngeal carcinoma: molecular biomarker discovery and progress Mol Cancer 6 2007 1
18. H. Karray, W. Ayadi, L. Fki, A. Hammami, J. Daoud, and M.M. Drira Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia J Med Virol 75 2005 593 602
19. S.B. Edge, D.R. Byrd, and C.C. Compton AJCC cancer staging manual 7th ed. 2009 Springer New York
20. International commission on radiation unit and measurements. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: ICRU; 1993.
21. Wambersie A, LT, ICRU Report 62: prescribing, recording and reporting photon beam therapy (Supplement to ICRU, Report 50); 1999.
22. K.P. Chang, C.L. Hsu, Y.L. Chang, N.M. Tsang, C.K. Chen, and T.J. Lee Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma Oral Oncol 44 2008 784 792
23. J.C. Lin, W.Y. Wang, K.Y. Chen, Y.H. Wei, W.M. Liang, and J.S. Jan Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2461 2470
24. Y.M. Lo, L.Y. Chan, K.W. Lo, S.F. Leung, J. Zhang, and A.T. Chan Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191
25. H. Fan, J. Nicholls, D. Chua, K.H. Chan, J. Sham, and S. Lee Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus Int J Cancer 112 2004 1036 1041
26. A.S. Abdulamir, R.R. Hafidh, F. Abu Bakar, and K. Abbas Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma Am J Otolaryngol 31 2010 410 417
27. R. Tedeschi, E. Pin, D. Martorelli, E. Bidoli, A. Marus, and C. Pratesi Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity Clin Vaccine Immunol 14 2007 435 441
28. H.C. Ho, H.C. Kwan, and M.H. Ng Immunohistochemistry of local immunoglobulin production in nasopharyngeal carcinoma Br J Cancer 37 1978 514 519
29. G. Niedobitek, A. Agathanggelou, and J.M. Nicholls Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma Semin Cancer Biol 7 1996 165 174
30. L.R. Begin, J. Eskandari, J. Joncas, and L. Panasci Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung J Surg Oncol 36 1987 280 283
31. T. Osato, and S. Imai Epstein-Barr virus and gastric carcinoma Semin Cancer Biol 7 1996 175 182
32. Y.L. Chang, C.T. Wu, J.Y. Shih, and Y.C. Lee New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas Am J Surg Pathol 26 2002 715 723
33. M.F. Ji, D.K. Wang, Y.L. Yu, Y.Q. Guo, J.S. Liang, and W.M. Cheng Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma Br J Cancer 96 2007 623 630